Literature DB >> 32884504

Evaluation of the in vitro Function of Platelet Concentrates from Pooled Buffy Coats or Apheresis.

Sarah Anna Fiedler1, Klaus Boller2, Ann-Christine Junker1, Christel Kamp3, Anneliese Hilger1, Wolfgang Schwarz1, Rainer Seitz1, Ursula Salge-Bartels1.   

Abstract

BACKGROUND: Platelet concentrates play an important role in transfusion medicine. Their short lifespan and lack of robustness require efforts to ensure adequate product quality. In this study, we compared the in vitro quality of the main concentrate types, pooled platelet concentrate (PPC) from whole blood donations, and platelet concentrate from single-donor apheresis (APC).
METHODS: Twenty PPCs and 20 APCs prepared in plasma were analyzed on days 2, 4, and 7 of storage. Variables related to metabolism, degranulation, platelet aggregation, P-selectin expression, and annexin V binding were analyzed. Morphology was assessed by transmission electron microscopy of ultrathin sections. A microfluidic device was applied to test the effects of shear stress on platelet function.
RESULTS: The metabolic parameters indicated stable storage conditions throughout the 7-day period. The resting discoid form was the prevailing morphology on days 2 and 4 in the PPCs and APCs. Chemokine release and receptor shedding of soluble P-selectin and soluble CD40L equally increased in PPCs and APCs. Aggregation responses to ADP and collagen were heterogeneous, with marked losses in collagen responsiveness on day 4 in individual concentrates. Baseline expression of P-selectin in PPCs and APCs was low, and inducibility of P-selectin was well preserved until day 4. Under shear stress, equal adhesiveness and stability were found with platelets from PPCs and APCs.
CONCLUSIONS: Platelets from PPCs and APCs showed similar in vitro function and stability parameters. However, platelet concentrates presented a high variability and individual concentrates an impaired functional capability. Identifying the factors contributing to this would help increase product reliability.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Fluidic system; Platelet aggregation; Platelet concentrates; Platelet function; Shear stress

Year:  2020        PMID: 32884504      PMCID: PMC7443689          DOI: 10.1159/000504917

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  27 in total

1.  In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.

Authors:  C P Turner; J Sutherland; M Wadhwa; P Dilger; R Cardigan
Journal:  Vox Sang       Date:  2005-04       Impact factor: 2.144

2.  Platelet function under high-shear conditions from platelet concentrates.

Authors:  Petra Jilma-Stohlawetz; Michaela Horvath; Beate Eichelberger; Daniela Koren; Bernd Jilma; Simon Panzer
Journal:  Transfusion       Date:  2007-09-24       Impact factor: 3.157

3.  Monitoring of platelet activation in platelet concentrates using transmission electron microscopy.

Authors:  Josef Neumüller; Claudia Meisslitzer-Ruppitsch; Adolf Ellinger; Margit Pavelka; Christof Jungbauer; Renate Renz; Gerda Leitner; Thomas Wagner
Journal:  Transfus Med Hemother       Date:  2013-03-14       Impact factor: 3.747

Review 4.  The influence of diet and nutrients on platelet function.

Authors:  Bradley J McEwen
Journal:  Semin Thromb Hemost       Date:  2014-02-04       Impact factor: 4.180

5.  Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.

Authors:  Sukhi Singh; Caroline Shams Hakimi; Anders Jeppsson; Camilla Hesse
Journal:  Transfus Apher Sci       Date:  2017-11-02       Impact factor: 1.764

6.  Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.

Authors:  Flavia Temperilli; Aldona Rina; Isabella Massimi; Anna Lisa Montemari; Maria Luisa Guarino; Alessandra Zicari; Fabio M Pulcinelli
Journal:  Platelets       Date:  2015-03-03       Impact factor: 3.862

7.  Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.

Authors:  L Eriksson; J Kristensen; K Olsson; J Bring; C F Högman
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

Review 8.  Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

Authors:  H Schrezenmeier; E Seifried
Journal:  Vox Sang       Date:  2009-01-04       Impact factor: 2.144

9.  High incidence of defective high-shear platelet function among platelet donors.

Authors:  Paul Harrison; Helen Segal; Charlene Furtado; Salim Verjee; Kampta Sukhu; Michael F Murphy
Journal:  Transfusion       Date:  2004-05       Impact factor: 3.157

10.  In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.

Authors:  R Cardigan; J Sutherland; M Garwood; S Bashir; C Turner; K Smith; V Hancock; M Wiltshire; C Pergande; L M Williamson
Journal:  Vox Sang       Date:  2007-11-22       Impact factor: 2.144

View more
  1 in total

1.  Triple apheresis platelet concentrate quality after pneumatic tube system, conveyor box, and courier transport: An observational study.

Authors:  Lena Reichert; Stefan Wallner; Ralph Burkhardt; Robert Offner; Norbert Ahrens; Viola Hähnel
Journal:  Health Sci Rep       Date:  2022-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.